Posted in | News | Automotive Materials

Miba Invests in Building a New Sintering Plant for Automotive Engines

The Miba Group, a strategic partner to the international engine and automotive industry, is building a new plant for sintered components in McConnelsville, Ohio. By mid-2010 the company will have invested 16.5 million U.S. dollars and created 60 new jobs.

The production facility will be built next to the existing bearings plant, Miba Bearings US. Components for passenger car engines and transmissions will be produced there beginning in the second half of 2009. With its new plant, Miba is well positioned to meet the increasing demand in North America for smaller, more efficient engines and transmissions and contributes to enhanced fuel economy and CO2 reduction.

"The sharp rise in fuel prices and growing environmental awareness of U.S. consumers are making smaller and more economical cars increasingly attractive. With our technology we are now supporting our North American customers make their products more efficient, more environmentally friendly and quieter," says Michael Niedersüß, Director of Sales and Marketing for the Miba Sinter Group. Miba technology for engines and transmissions contributes to the reduction of fuel consumption and emissions by 15 to 25% compared with the vehicles currently on the road in the U.S.

The groundbreaking ceremony for Miba Sinter USA will take place later this year. The start of production is scheduled for mid-2009. In addition to the major U.S. automakers and suppliers, Miba will supply primarily European customers in North America.

For more information on automotive, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.